Huadong medicine Co.,Ltd.

About Huadong medicine Co.,Ltd.

,,Huadong medicine was established in 1993, headquartered in Hangzhou, China, is China's top 10 listed pharmaceutical and medical companies. The Company has more than 11,000 employees. In 2021, the Company's revenue stood at about 5.3billion USD. Huadong medicine are manufactuers of finished medicine, APIs and aesthetic medicine.
our APIs relate to the area of immunosuppressant, anti-diobetic agents, anti-infection, anti-tumor/ ADC toxin, nucleoside/nucleotide drugs. Our main products include: Acarbose, Cyclosporine, Febuxostat, Mycophenolate Mofetil, Orlistat,...

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 5000+
    Employees
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Generic APIs producer
Pharmaceutical Company (generic finished products)
Contact info
Meet us at

CPHI Barcelona 2023

Fira Barcelona, Spain
24-26 October 2023

Products from Huadong medicine Co.,Ltd. (5)

  • Acarbose

    Product Acarbose

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes acarbose. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Corbrin capsule

    Product Corbrin capsule

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes corbrin capsule. It belongs to formulation category. Functions: nourishes lung and kidney and benefits vital essence. It’s effective for the treatment of cough, asthma, chronic kidney trouble, chroni...
  • Cyclosporine

    Product Cyclosporine

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cyclosporine. It belongs to active pharmaceutical ingredient category. Contact us for more information.
  • Cycopin

    Product Cycopin

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cycopin. It belongs to formulation category. Indication: use to prevent rejection in allograft renal transplant recipient and to treat refractory rejection. Mycophenolate mofetil dispersible table could b...
  • Cymusi

    Product Cymusi

    Hangzhou Zhongmei Huadong Pharmaceutical provides wide range of pharmaceutical products which includes cymusi. It belongs to formulation category. Indication: indicated to renal transplant recipient to prevent rejection. Contact us for more information.